Latest Insider Transactions at Myriad Genetics Inc (MYGN)
This section provides a real-time view of insider transactions for Myriad Genetics Inc (MYGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYRIAD GENETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYRIAD GENETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,669
-0.5%
|
$61,387
$23.72 P/Share
|
|
Mar 24
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,816
-1.28%
|
$64,768
$23.72 P/Share
|
|
Mar 24
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.66%
|
$21,091
$23.72 P/Share
|
|
Mar 24
2023
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
987
-1.63%
|
$22,701
$23.72 P/Share
|
|
Mar 22
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,399
-1.97%
|
$30,778
$22.91 P/Share
|
|
Mar 22
2023
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
751
-1.47%
|
$16,522
$22.91 P/Share
|
|
Mar 22
2023
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
388
-1.24%
|
$8,536
$22.91 P/Share
|
|
Mar 22
2023
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,046
-1.56%
|
$441,012
$22.91 P/Share
|
|
Mar 22
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,074
-1.07%
|
$89,628
$22.91 P/Share
|
|
Mar 22
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,419
-0.95%
|
$53,218
$22.91 P/Share
|
|
Mar 22
2023
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,351
-0.51%
|
$29,722
$22.91 P/Share
|
|
Mar 22
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,677
-1.49%
|
$36,894
$22.91 P/Share
|
|
Mar 22
2023
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,432
-1.94%
|
$31,504
$22.91 P/Share
|
|
Mar 15
2023
|
Natalie Munk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.14%
|
-
|
|
Mar 15
2023
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,459
+20.16%
|
-
|
|
Mar 15
2023
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,459
+28.56%
|
-
|
|
Mar 15
2023
|
Paul J Diaz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
197,023
+13.3%
|
-
|
|
Mar 15
2023
|
Nicole Lambert Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,405
+13.4%
|
-
|
|
Mar 15
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,783
+10.29%
|
-
|
|
Mar 15
2023
|
Pamela Wong Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,892
+22.89%
|
-
|
|
Mar 15
2023
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
16,419
+24.35%
|
-
|
|
Mar 15
2023
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,405
+12.84%
|
-
|
|
Mar 02
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.25%
|
$330,000
$22.55 P/Share
|
|
Mar 02
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,184
-5.77%
|
$290,048
$22.74 P/Share
|
|
Mar 01
2023
|
Shereen Solaiman Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,856
+50.0%
|
-
|
|
Feb 25
2023
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,556
-6.88%
|
$46,008
$18.54 P/Share
|
|
Feb 25
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,012
-1.19%
|
$18,216
$18.54 P/Share
|
|
Feb 18
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,222
-3.08%
|
$213,218
$19.42 P/Share
|
|
Jan 20
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,400
-2.52%
|
$188,000
$20.04 P/Share
|
|
Jan 18
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600
-0.16%
|
$12,000
$20.01 P/Share
|
|
Jan 01
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
853
-0.37%
|
$11,942
$14.51 P/Share
|
|
Jan 01
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
302
-0.7%
|
$4,228
$14.51 P/Share
|
|
Dec 27
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-5.07%
|
$300,000
$15.15 P/Share
|
|
Oct 31
2022
|
Paul Bisaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,875
+50.0%
|
-
|
|
Oct 18
2022
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,318
-3.05%
|
$66,360
$20.0 P/Share
|
|
Oct 09
2022
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
309
-0.71%
|
$5,871
$19.62 P/Share
|
|
Oct 09
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,385
-1.53%
|
$235,315
$19.62 P/Share
|
|
Oct 09
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,366
-1.78%
|
$158,954
$19.62 P/Share
|
|
Oct 09
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,118
-2.54%
|
$230,242
$19.62 P/Share
|
|
Oct 09
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,926
-1.4%
|
$93,594
$19.62 P/Share
|
|
Oct 09
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,721
-1.98%
|
$32,699
$19.62 P/Share
|
|
Sep 26
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,216
-1.23%
|
$39,888
$18.41 P/Share
|
|
Sep 26
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,543
-1.11%
|
$81,774
$18.41 P/Share
|
|
Sep 26
2022
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.31%
|
$2,394
$18.41 P/Share
|
|
Sep 26
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,293
-0.96%
|
$41,274
$18.41 P/Share
|
|
Sep 26
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,950
-1.21%
|
$53,100
$18.41 P/Share
|
|
Sep 26
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
862
-0.98%
|
$15,516
$18.41 P/Share
|
|
Sep 25
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,662
-0.92%
|
$29,916
$18.69 P/Share
|
|
Sep 25
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,263
-1.26%
|
$94,734
$18.69 P/Share
|
|
Sep 25
2022
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
345
-0.79%
|
$6,210
$18.69 P/Share
|